Complete Loss of EPCAM Immunoexpression Identifies EPCAM Deletion Carriers in MSH2-Negative Colorectal Neoplasia

SIMPLE SUMMARY: Colorectal carcinomas from patients with Lynch syndrome (LS) due to EPCAM deletions show loss of MSH2 expression. The aim of our study was to evaluate the usefulness of EPCAM expression in identifying carriers of EPCAM deletion among patients with MSH2-negative lesions. MSH2 and EPCA...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Main Authors: Cuatrecasas, Míriam, Gorostiaga, Iñigo, Riera, Cristina, Saperas, Esteban, Llort, Gemma, Costa, Irmgard, Matias-Guiu, Xavier, Carrato, Cristina, Navarro, Matilde, Pineda, Marta, Dueñas, Núria, Brunet, Joan, Marco, Vicente, Trias, Isabel, Busteros, José Ignacio, Mateu, Gemma, Balaguer, Francesc, Fernández-Figueras, María-Teresa, Esteller, Manel, Musulén, Eva
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7599495/
https://ncbi.nlm.nih.gov/pubmed/33003511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102803
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares